Use of the transtheoretical model in the medication use process

Annals of Pharmacotherapy

Volumn 39, Issue 7-8, 2005, Pages 1325-1330

  Ficke, Danielle L ^a   Farris, Karen B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Patient adherence; Prescription drugs; Theoretical model

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA1A INTERFERON; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDINAVIR; NELFINAVIR; RITONAVIR; SAQUINAVIR;

ADULT; CLINICAL PRACTICE; DECISION MAKING; DRUG UTILIZATION; HUMAN; PATIENT COMPLIANCE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; THEORETICAL MODEL;

DRUG THERAPY; DRUG UTILIZATION; HUMANS; LIFE STYLE; MODELS, THEORETICAL; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS;

EID: 21744449639     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G122     Document Type: Review

References (24)

1. Nigg CR, Burbank PM, Padula C, Dufresne R, Rossi JS, Velicer WF, et al. Stages of change across ten health risk behaviors for older adults. Geronotologist 1999;39:473-82.
2. Spencer L, Pagell F, Hallion ME, Adams TB. Applying the transtheoretical model to tobacco cessation and prevention: a review of literature. Am J Health Prom 2002;17:7-71.
3. Wilson GT, Schlam TR. The transtheoretical model and motivation interviewing in the treatment of eating and weight disorders. Clin Psychol Rev 2004;24:361-78.
4. Horowitz SM. Applying the transtheoretical model to pregnancy and STD prevention: review of the literature. Am J Health Prom 2003;17: 304-38.
5. Sutton S. Back to the drawing board? A review of applications of the transtheoretical model to substance use. Addiction 2001;96:175-86.
6. DiClemente CC, Schlundt D, Gemmell L. Readiness and stages of change in addiction treatment. Am J Addiction 2004;13:103-19.
7. Adams J, White M. Are activity promotion interventions based on the transtheoretical model effective? A critical review. Br J Sports Med 2003;37:106-14.
8. Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. In: Glanz K, Rimer BK, Lewis FM, eds. Health behavior and health education: theory, research, and practice. 3rd ed. San Francisco: Jossey Bass, 2002:99-116.
9. Treating tobacco use and dependence (revised 2000): clinical practice guideline. U.S. Department of Health and Human Services, Public Health Service, June 2000. www.ncbi.nlm.nih.gov/books/bv.fcgi?rid= hstat2.chapter.7644 (accessed 2005 Feb 28).
10. Cook CL, Perri M 3rd. Single-item vs multiple-item measures of stage of change in compliance with prescribed medications. Psychol Rep 2004: 94:115-24.
11. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Therapeutics 2000;22:858-71.
12. Johnson SS, Grimley DM, Prochaska JO. Prediction of adherence using the transtheoretical model: implications for pharmacy care practice. J Soc Admin Pharm 1998;15:135-48.
13. Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change. J Am Pharm Assoc 2004;44:445-54.
14. Corelli RL, Hudmon KS. Promoting treatment adherence in diabetes: a practical strategy for pharmacists. Calif J Health Syst Pharm 1999;Sept/Oct:12-6.
15. Sher TG, Bellg AJ, Braun L, Domas A. Rosenson R, Canar WJ. Partners for life: a theoretical approach to developing an intervention for cardiac risk reduction. Health Educ Res Theory Pract 2002;17:597-605.
16. Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999;1:477-81.
17. Tuldra A, Wu AW. Interventions to improve adherence to antiretroviral therapy. J Acquire Immune Defic Syndr 2002;31:S154-7.
18. Robbins ML. Medication adherence and the transplant recipient: helping patients at each stage of change. Transplant Proc 1999;31(suppl 4A): 29S-30S.
19. Roughead EE, Gilbert AL, Primrose JG. Improving drug use: a case study of events which led to changes in use of flucloxacillin in Australia. Soc Sci Med 1999;48:845-53.
20. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc 1997;NS37:535-42.
21. Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002;25:355-72.
22. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005;39: 319-28. Epub 2005 Jan 4. DOI 10.1345/aph.1E027
23. Takiya LN, Peterson AM, Finley RS. Meta-analysis of interventions for medication adherence to antihypertensives. Ann Pharmacother 2004;38: 1617-24. Epub 2004 Aug 10. DOI 10.1345/aph.1D268
24. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002;(2):CD000011.